高榕创投
@gaorong
创造美好生活
497 articles
Jinghe Biotech Closes Nearly RMB 400 Million Series B Round, Continues to Lead Domestic Targeted Radiopharmaceutical Innovation
Patient-centered, relentlessly refined.
高榕创投·
ASTRONSTONE Raises 1 Billion RMB, Racing Toward First Flight of Reusable Medium-to-Heavy Launch Vehicle
Gaorong Ventures co-led the round.
高榕创投·
"Zhongsheng Quanpeptide" Raises Over 300 Million Yuan in Series C Funding to Accelerate Global Expansion of Peptide-Based Innovative Drugs
It has secured multiple international partnerships with MNCs including Novartis and Eli Lilly and Company.
高榕创投·
Qinghe Technology Delivers First Batch of Color Photoresist: A Milestone for China's Display Supply Chain! --- Qinghe Technology (清荷科技) has completed mass production and delivery of its first batch of color photoresist, marking a significant breakthrough in a critical material long dominated by foreign suppliers in China's display industry. Color photoresist is an essential component in the manufacturing of LCD and OLED panels, used to create the red, green, and blue subpixels that produce full-color images. The material demands extremely high precision in color purity, photosensitivity, and stability — technical barriers that have historically left Chinese display makers dependent on imports from Japanese and Korean chemical companies. This domestic production milestone comes as China's flat-panel display industry, the world's largest by capacity, faces increasing pressure to secure local supply chains amid geopolitical tensions and supply volatility. Industry analysts note that while Chinese manufacturers have made rapid progress in display panel production itself, upstream materials — particularly high-purity photoresists, polarizers, and driver ICs — remain concentrated among a handful of foreign suppliers. Qinghe's achievement represents incremental but meaningful progress in closing this gap. The company has not disclosed specific customers or volume figures for this initial delivery.
Accelerating the domestic substitution of core materials in the display industry.
高榕创投·
Rong Report | HT Aero, Xiwang, Helixon and Others Close Major Funding Rounds; Moonshot AI and Momenta Release Leading Models
Major Funding + Leading Model + Mass Production
高榕创投·
Moonshot AI's K2.6 Model Is Here: Major Leaps in Long-Range Coding and Agent Swarm Capabilities!
Talk is cheap. Show me the code.
高榕创投·
Pulnovo Medical Completes $100 Million Series D Round Led by Medtronic, with Gaorong Ventures Continuing to Invest
Medtronic and Pulnovo Medical have signed a commercial cooperation agreement.
高榕创投·
The "Whole-Team Lobsterization" Playbook at an AI Startup: 30 People × 70x Efficiency Leverage | Gaorong Future
"Tokens as Combat Power"
高榕创投·
Nova Fusion Closes Massive 700 Million Yuan Angel+ Round, Aiming for the Global First Tier of Commercial Fusion
Fusion for AI & Beyond
高榕创投·
Microsoft China CTO + 3 Claw Product Builders: From Lobster Working to Lobster Business | Ronghui
Practical Claw Applications Across Three Scenarios: Personal Agents, Financial Research, and Cloud Assistants
高榕创投·
Helixon Raises $787 Million, Setting a New Global Record for Biotech Fundraising This Year
Accelerating the transformation of AI innovations into potentially transformative medicines.
高榕创投·
Wobrain Medical Completes Strategic Funding Round to Accelerate Global Expansion in Neurovascular Medical Technology
Completed a strategic merger to accelerate global expansion.
高榕创投·